Cours Neuropathix, Inc.
Actions
NPTX
US64132Q1094
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 25/07/18 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 25/07/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 20/06/17 |
Timothy Scott
BRD | Director/Board Member | 71 | 25/07/18 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,73 % | 108 Md | |
+9,59 % | 103 Md | |
+6,58 % | 23,48 Md | |
-12,59 % | 21,93 Md | |
-3,29 % | 19,68 Md | |
-35,36 % | 18,37 Md | |
-13,29 % | 16,33 Md | |
+4,68 % | 13,72 Md | |
+34,25 % | 12,15 Md |